Products for Research Use Only

APAF1 Peptide

CAT: 0796-AF0117-BPSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0796-AF0117-BPSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
For modified antibodies, we provide modified peptides(0.5mg) and non-modified peptides (0.5 mg).
Reactivity
Antibody available as AF0117
Source
Synthetic
Applications
Blocking/Control
Concentration
10 mg/mL
Function
Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.
Related Products
AF0117

Alternative Products

CatalogName
MBS152524-01Apaf1 Peptide
MBS9626933-01APAF1 Blocking Peptide
MBS9616415-01Phospho-APAF1 (Ser320) Blocking Peptide
149494NALP6, Control Peptide (NACHT, LRR and PYD Domains-containing Protein 6, PYRIN-containing APAF1-like Protein 5, NLRP6, PYPAF5)
N0018-63ANALP2, Control Peptide (NACHT-, LRR- and PYD-Containing Protein 2, PYRIN-containing APAF1-like Protein 2, Nucleotide-Binding Site Protein 1)
149495NALP7, Control Peptide (NACHT, LRR and PYD Domains-containing Protein 7, Nucleotide-binding Oligomerization Domain Protein 12, PYRIN-containing APAF1-like Protein 3, NALP7, NOD12, PYPAF3)
149498NALP11, Control Peptide (NACHT, LRR and PYD Domains-containing Protein 11, Nucleotide-binding Oligomerization Domain Protein 17, PAAD-and NACHT Domain-containing Protein 10, PYRIN-containing APAF1-like Protein 6, NLRP11, NOD17, PAN10, PYPAF6)
149499NALP12, Control Peptide (NACHT LRR and PYD Domains-containing Protein 12, CLR19.3, FCAS2, Monarch 1, Monarch-1, NLR Family Pyrin Domain Containing 12, NLRP12, PAN6, PYRIN Containing APAF1-like Protein 7, PYPAF7, Regulated by Nitric Oxide, RNO, RNO2)
147803NLRP3, Control Peptide (NACHT, LRR and PYD Domains-containing Protein 3, Angiotensin/Vasopressin Receptor AII/AVP-like, Caterpiller Protein 1.1, CLR1.1, Cold Autoinflammatory Syndrome 1 Protein, Cryopyrin, PYRIN-containing APAF1-like Protein 1, C1orf7, CIAS1, NALP3, PYPAF1, FLJ95925)
149313NALP3, Control Peptide (NACHT, LRR and PYD Domains-containing Protein 3, Angiotensin/Vasopressin Receptor AII/AVP-like, Caterpiller Protein 1.1, CLR1.1, Cold Autoinflammatory Syndrome 1 Protein, Cryopyrin, PYRIN-containing APAF1-like Protein 1, C1orf7, CIAS1, NALP3, PYPAF1, FLJ95925)